Maladies inflammatoires de l'intestin [Inflammatory diseases of the intestines]
Details
Serval ID
serval:BIB_FCC41CACED75
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Maladies inflammatoires de l'intestin [Inflammatory diseases of the intestines]
Journal
Revue médicale suisse
ISSN
1660-9379
Publication state
Published
Issued date
01/2006
Volume
2
Number
49
Pages
191-194, 196-198, 201-203
Language
french
Notes
Publication types: English Abstract ; Journal Article ; Review - Publication Status: ppublish
Abstract
5-aminosalicylates preparations are not superior to placebo for the maintenance of medically-induced remission in patients with Crohn's disease. We have to reconsider the potential risks associated with inhibition of lymphocyte trafficking since it can induce serious and potentially lethal infections. Infliximab has shown efficacy in active ulcerative colitis.
Keywords
Adrenal Cortex Hormones/therapeutic use, Anti-Inflammatory Agents, Non-Steroidal/therapeutic use, Antibodies, Monoclonal/therapeutic use, Colitis, Ulcerative/drug therapy, Colitis, Ulcerative/immunology, Crohn Disease/drug therapy, Crohn Disease/immunology, Gastrointestinal Agents/therapeutic use, Humans, Mesalamine/therapeutic use, Risk Factors
Pubmed
Create date
25/01/2008 16:58
Last modification date
20/08/2019 17:27
Usage data
